StockWatch
·
Q2 FY-2027 RESULTS · SURAJEST

Suraj Estate Q2FY27: consolidated PAT falls 30% YoY to ₹23 Cr despite 18% revenue growth

PAT -30.29% YoY · revenue +17.63% · margins compressing · miss vs street

Q2 FY27 resultsSURAJESTSuraj Estate Developers Ltd31 Oct 2026 · 3 min read
Revenue

₹170.04 Cr

+17.63% YoY

PAT (consolidated)

₹23.07 Cr

-30.29% YoY

Net margin

13.48%

-9.3pp YoY

EPS

₹4.98

Suraj Estate Developers' consolidated PAT fell 30.3% YoY to ₹23.07 Cr in Q2 FY27 (from ₹33.09 Cr), even as consolidated revenue from operations grew 17.6% YoY to ₹170.04 Cr (from ₹144.56 Cr). Sequentially, PAT was roughly flat (+1.0% QoQ versus ₹22.85 Cr in Q1 FY27) while revenue rose 17.5% QoQ — so the decline is purely a year-on-year story, not a sequential one, and with no exceptional items on either side of the comparison the decline is organic margin compression rather than a base effect.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹170.04 Cr+17.5%+17.6%
Expenses₹140.13 Cr+21.9%+38.3%
PAT₹23.07 Cr+0.96%-30.29%
Net margin13.48%-2.2pp-9.3pp
EPS₹4.98+0.8%-30.3%

Total expenses rose to 81.9% of total income from 69.7% a year ago (78.6% last quarter), pulling net profit margin down to 13.5% from 22.8% YoY (15.6% QoQ). Finance costs were a specific contributor, up 19.1% YoY to ₹24.39 Cr as borrowings climbed — gross debt stood at roughly ₹799.5 Cr at quarter-end versus ₹642.0 Cr at FY26 year-end — consistent with management's prior guidance that net debt (then ₹614 Cr) would rise temporarily to fund capacity build, including the ₹82.72 Cr Mahim land-rights acquisition closed September 25, 2026. Quarterly EBITDA margin came in near 33.0%, below the FY27 guided 35-37% band, though cumulative H1 FY27 EBITDA margin of ~35.1% still sits just inside the low end of that range.

₹
161.27178.14195211.86228.73172.107-2808-1909-1010-0610-2910-30
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹172.1, down 17.5% over the past month of trading.

₹ Cr
012.3624.7137.0721.28Q1 FY26rev ₹132 Cr33.09Q2 FY26rev ₹145 Cr25.17Q3 FY26rev ₹180 Cr10.76Q4 FY26rev ₹99 Cr22.85Q1 FY27rev ₹145 Cr23.07Q2 FY27rev ₹170 Cr
Quarterly consolidated PAT, ₹ Crore

For context: PAT has now risen for 2 consecutive quarters.

What management guided (1 FY-2027 call)
FY27 revenue growth 10–15% on ₹1,600 Cr launch pipeline (vs ₹1,400 Cr prior); presales target ₹700 Cr (internally higher); EBITDA margin 35–37%; net debt ₹614 Cr, rising temporarily for capacity build.

— This quarter: met

Management's FY27 guidance called for 10-15% revenue growth; H1 FY27 consolidated revenue grew 13.6% YoY (₹314.76 Cr vs ₹277.03 Cr), tracking within that band even as the quarterly margin undershoot is a watch item. No formal Street consensus for this specific quarter turned up; the closest available read is an analyst FY27 PAT growth projection of 15-20% (univest.in) — this quarter's 30% YoY PAT decline runs well short of that full-year pace, though one quarter alone doesn't confirm a miss on the annual number. No press release or management commentary on this print was available to weigh against the figures. Standalone tells a materially different story than consolidated: standalone revenue fell 51.1% YoY to ₹69.03 Cr (from ₹141.08 Cr) and standalone PAT fell 47.2% YoY to ₹19.07 Cr (from ₹36.10 Cr) — a sharp divergence from consolidated's growth, indicating a growing share of billing is being recognized at the subsidiary/SPV level rather than in the standalone entity.

  • W1

    Whether Q3-Q4 FY27 EBITDA margin recovers to the guided 35-37% band after Q2's ~33.0% print (H1 at ~35.1%)

  • W2

    Execution on the ₹1,600 Cr launch pipeline and ₹700 Cr presales target flagged last quarter, needed to sustain 10-15% FY27 revenue growth guidance (13.6% YoY in H1)

  • W3

    Net debt trajectory — gross debt already ~₹799.5 Cr (from ~₹642.0 Cr at FY26-end) against the 'temporary' rise management guided from a ₹614 Cr base

No exceptional/one-off items in either statement; standalone and consolidated diverge sharply (standalone revenue -51% YoY vs consolidated +18% YoY), pointing to more billing shifting to subsidiary/SPV level; filing notes prior-year standalone comparatives were originally reported in Rs millions and reclassified to Rs lakhs this quarter.

Informational and educational content only. Not investment advice.